
SEMAGLUTIDE for Weight Loss
Semaglutide injections for weight loss
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes, now FDA-approved for weight management under the name Wegovy. It works by mimicking a natural hormone that helps regulate appetite and food intake—reducing hunger, increasing fullness, and lowering overall calorie consumption.
Taken once weekly by subcutaneous injection, semaglutide has been shown in clinical trials to deliver consistent, significant weight loss when combined with diet and exercise.
It’s best suited for adults with a BMI over 30, or over 27 with a weight-related condition like high blood pressure or type 2 diabetes. Most patients see results within weeks, with the full benefit building over several months.
FAQ
Semaglutide is a medication that belongs to a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Originally developed to treat type 2 diabetes, semaglutide has also been studied for its potential to aid in weight loss.
Semaglutide works by mimicking the action of glucagon-like peptide-1 (GLP-1), a hormone that helps regulate appetite, food intake, and body weight. By activating GLP-1 receptors in the brain, semaglutide can help decrease appetite, increase feelings of fullness, and reduce calorie intake, leading to weight loss.
Yes, semaglutide has been approved by the U.S. Food and Drug Administration (FDA) for chronic weight management in adults with obesity or overweight who have at least one weight-related comorbidity (such as high blood pressure, type 2 diabetes, or high cholesterol). It is sold under the brand name Wegovy.
Clinical trials have shown that semaglutide can lead to significant weight loss when used as part of a comprehensive weight management program. In trials, participants treated with semaglutide experienced greater weight loss compared to those treated with placebo or other weight loss medications.
Semaglutide may be a suitable option for adults with obesity or overweight who have not been able to achieve or maintain weight loss through diet and exercise alone. It is typically recommended for individuals with a body mass index (BMI) of 30 kg/m² or higher, or a BMI of 27 kg/m² or higher with at least one weight-related comorbidity.
Semaglutide is administered by subcutaneous injection once weekly. The recommended starting dose is 0.25 mg once weekly, with the dose gradually increased to 2.4 mg once weekly over a period of 16 to 20 weeks, as tolerated.
Common side effects of semaglutide may include nausea, vomiting, diarrhea, constipation, abdominal pain, and decreased appetite. These side effects often improve over time as the body adjusts to the medication. In rare cases, semaglutide may cause more serious side effects, such as pancreatitis or thyroid tumors.
Semaglutide has been studied for long-term use in clinical trials, and it is generally considered safe and effective when used as prescribed. However, like any medication, it may carry certain risks, especially when used for an extended period. It’s essential to discuss the potential benefits and risks of long-term semaglutide use with a healthcare provider.
Semaglutide may be used alone or in combination with other weight loss medications, such as phentermine, as part of a comprehensive weight management program. However, combining weight loss medications may increase the risk of side effects, so it’s important to consult with a healthcare provider before starting any new medications.
Insurance coverage for semaglutide for weight loss may vary depending on the individual’s insurance plan and the specific criteria set by the insurer. Some insurance plans may cover semaglutide for weight loss, especially for individuals with obesity or overweight who have weight-related comorbidities. However, coverage may be subject to prior authorization or other requirements.
These are some common questions and answers about semaglutide for weight loss. It’s important to consult with a healthcare provider to determine if semaglutide is the right treatment option for you and to discuss any concerns or questions you may have.
